News and Announcements
4Dx to Present at Lung Imaging Workshop in the U.S.
- Published February 20, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4Dx Limited is a medical technology start-up based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology.
KEY TAKEAWAYS:
- Dr Andreas Fouras, founder and CEO of medical technology company 4Dx Limited, will present at the World Lung Imaging Workshop at the University of Pennsylvania.
“The software developed by 4Dx provides richer information, allowing for earlier detection of respiratory related disease. It captures images that effectively visualise and quantify motion of airflow at high resolution within the breathing lungs.
The company has a range of formal engagements with some leading institutions across the United States and is moving towards a commercial product in the US by 2018.”
Company Updates
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
Relying solely on broad macroeconomic trends is the single biggest mistake property investors make today. Centuria Capital CIO Andrew Essey explains why asset-level “lettability” always trumps the overarching sector thematic, and reveals where global institutional capital is quietly pivoting to capture high-octane returns.
Backed By Leading Investment Groups and Family Offices
